Pacific Edge is pleased to present the latest edition of its regular Investor Newsletter.
Included in this issue:
• Welcome from the Chair
• CEO’s Update
• Portfolio of clinical evidence continues to grow, driving adoption
• A focus on growth in the US COVID environment
• Positive coverage decision issued by United Healthcare
• Understanding our business: US Academic Medical Centres
• Welcome to new director, Anna Stove
• Introducing Tony Lough, VP Clinical Science and Product Performance
“ANZ NZ will continue to defend its case. Our position hasn’t changed.”
The S&P/NZX 50 Index closed at 13,531.29, up 42.05 points or 0.31%.
It ended a four-year class action centred on disclosure obligations.
To join your company account for BusinessDesk and enjoy full access, enter your email and we’ll send you details